123 related articles for article (PubMed ID: 37776720)
41. Is lobe-specific lymph node dissection appropriate in lung cancer patients undergoing routine mediastinoscopy?
Turna A; Solak O; Kilicgun A; Metin M; Sayar A; Gürses A
Thorac Cardiovasc Surg; 2007 Mar; 55(2):112-9. PubMed ID: 17377865
[TBL] [Abstract][Full Text] [Related]
42. Surgical Results in Pathological N1 Nonsmall Cell Lung Cancer.
Yoshida Y; Yotsukura M; Nakagawa K; Watanabe H; Motoi N; Watanabe SI
Thorac Cardiovasc Surg; 2021 Jun; 69(4):366-372. PubMed ID: 32634835
[TBL] [Abstract][Full Text] [Related]
43. Complete thoracic mediastinal lymphadenectomy leads to a higher rate of pathologically proven N2 disease in patients with non-small cell lung cancer.
Cerfolio RJ; Bryant AS; Minnich DJ
Ann Thorac Surg; 2012 Sep; 94(3):902-6. PubMed ID: 22776083
[TBL] [Abstract][Full Text] [Related]
44. Survival and Resected Lymph Node Number During Sublobar Resection for N0 Non-Small Cell Lung Cancer 2 cm or Less.
Ding H; Wang H; Xu L; Song N; Jiang G
Ann Thorac Surg; 2019 Jun; 107(6):1647-1655. PubMed ID: 30682353
[TBL] [Abstract][Full Text] [Related]
45. Video-assisted vs open mediastinal lymphadenectomy for Stage I non-small-cell lung cancer: results of a prospective randomized trial.
Palade E; Passlick B; Osei-Agyemang T; Günter J; Wiesemann S
Eur J Cardiothorac Surg; 2013 Aug; 44(2):244-9; discussion 249. PubMed ID: 23295451
[TBL] [Abstract][Full Text] [Related]
46. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
[TBL] [Abstract][Full Text] [Related]
47. Lymph node yield after colectomy for cancer: is absence of mismatch repair a factor?
Samdani T; Schultheis M; Stadler Z; Shia J; Fancher T; Misholy J; Weiser MR; Nash GM
Dis Colon Rectum; 2015 Mar; 58(3):288-93. PubMed ID: 25664706
[TBL] [Abstract][Full Text] [Related]
48. Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer.
Tamura M; Matsumoto I; Saito D; Yoshida S; Takata M; Takemura H
World J Surg Oncol; 2016 Nov; 14(1):295. PubMed ID: 27884195
[TBL] [Abstract][Full Text] [Related]
49. Negative Lymph Node Count Predicts Survival of Resected Non-small Cell Lung Cancer.
Zhou X; Wu C; Cheng Q
Lung; 2020 Oct; 198(5):839-846. PubMed ID: 32683563
[TBL] [Abstract][Full Text] [Related]
50. Clinical implications of uncertain resection in scenarios of metastasis of the highest or most distant mediastinal lymph node station following surgical treatment of non-small-cell lung cancer.
Park SY; Byun GE; Lee CY; Lee JG; Kim DJ; Paik HC; Chung KY
Lung Cancer; 2019 Dec; 138():1-5. PubMed ID: 31593893
[TBL] [Abstract][Full Text] [Related]
51. Lobe-specific lymph node dissection in stage IA non-small-cell lung cancer: a retrospective cohort study.
Abughararah TZ; Jeong YH; Alabbood F; Chong Y; Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Eur J Cardiothorac Surg; 2021 Apr; 59(4):783-790. PubMed ID: 33150427
[TBL] [Abstract][Full Text] [Related]
52. The Role of Lung Cancer Surgical Technique on Lymph Node Sampling and Pathologic Nodal Upstaging.
Kalata S; Mollberg NM; He C; Clark M; Theurer P; Chang AC; Welsh RJ; Lagisetty KH
Ann Thorac Surg; 2023 May; 115(5):1238-1245. PubMed ID: 36240869
[TBL] [Abstract][Full Text] [Related]
53. Lobe-specific mediastinal nodal dissection is sufficient during lobectomy by video-assisted thoracic surgery or thoracotomy for early-stage lung cancer.
Shapiro M; Kadakia S; Lim J; Breglio A; Wisnivesky JP; Kaufman A; Lee DS; Flores RM
Chest; 2013 Nov; 144(5):1615-1621. PubMed ID: 23828253
[TBL] [Abstract][Full Text] [Related]
54. Frequency of noncontiguous lymph node involvement in patients with resectable nonsmall cell lung carcinoma.
Bonner JA; Garces YI; Sawyer TE; Gould PM; Foote RL; Deschamps C; Lange CM; Li H
Cancer; 1999 Oct; 86(7):1159-64. PubMed ID: 10506699
[TBL] [Abstract][Full Text] [Related]
55. Stage migration: results of lymph node dissection in the era of modern imaging and invasive staging for lung cancer.
Kirmani BH; Rintoul RC; Win T; Magee C; Magee L; Choong C; Wells FC; Coonar AS
Eur J Cardiothorac Surg; 2013 Jan; 43(1):104-9; discussion 109-10. PubMed ID: 22529185
[TBL] [Abstract][Full Text] [Related]
56. Subcarinal Lymph Nodes Should be Dissected in All Lobectomies for Non-Small Cell Lung Cancer-Regardless of Primary Tumor Location.
Eckardt J; Jakobsen E; Licht PB
Ann Thorac Surg; 2017 Apr; 103(4):1121-1125. PubMed ID: 28109572
[TBL] [Abstract][Full Text] [Related]
57. Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer.
Muraoka M; Akamine S; Oka T; Tagawa T; Nakamura A; Tsuchiya T; Hayashi T; Nagayasu T
Eur J Cardiothorac Surg; 2007 Aug; 32(2):356-61. PubMed ID: 17513118
[TBL] [Abstract][Full Text] [Related]
58. The importance of lymph node dissection accompanying wedge resection for clinical stage IA lung cancer.
Stiles BM; Kamel MK; Nasar A; Harrison S; Nguyen AB; Lee P; Port JL; Altorki NK
Eur J Cardiothorac Surg; 2017 Mar; 51(3):511-517. PubMed ID: 28007869
[TBL] [Abstract][Full Text] [Related]
59. Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer.
Zhang YK; Chai ZD; Tan LL; Wang ZY; Chen ZJ; Le HB; Zhu WY
World J Surg Oncol; 2017 Mar; 15(1):64. PubMed ID: 28302176
[TBL] [Abstract][Full Text] [Related]
60. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
Qiu C; Dong W; Su B; Liu Q; Du J
J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
